Hutchmed (China) Ltd on Thursday said it has agreed to divest a 45% stake in Shanghai Hutchison Pharmaceuticals Ltd t ...
Hutchmed (China) Limited 02 January 2025 Press Release HUTCHMED Announces NDA Acceptance in China with Priority Review Status for ORPATHYS® and TAGRISSO® Combination in Lung Cancer...
Hutchmed (China) Limited 02 January 2025 Overseas Regulatory Announcement - Disposal Transaction HUTCHMED (China) Limited ("HUTCHMED") notes the below text, which is from an...
Hutchmed (China) Limited 02 January 2025 HUTCHMED Announces US$608 million Divestment of Non-Core Joint Venture - HUTCHMED continues to deliver on its strategy outlined in November 2022 to...
Hutchmed (China) Limited 31 December 2024 Appointment of Cavendish as Joint Corporate Broker in London Hong Kong, Shanghai & Florham Park, NJ - Tuesday, December 31, 2024: HUTCHMED...
Hutchmed (China) Limited 30 December 2024 Blocklisting Six Monthly Return Hong Kong, Shanghai & Florham Park, NJ - Monday, December 30, 2024: HUTCHMED (China) Limited ("HUTCHMED" or...
Ltd - Hong Kong-based biopharmaceutical firm - Is to receive a USD10 million milestone payment from partner Takeda Pha ...
Hutchmed (China) Limited 13 December 2024 Press Release HUTCHMED to Receive Milestone Payment from Takeda following First European Reimbursement for FRUZAQLA® (fruquintinib) - US$10...
Hutchmed (China) Limited 12 December 2024 Press Release HUTCHMED Announces Breakthrough Therapy Designation in China for ORPATHYS® and TAGRISSO® Combination in Certain Lung Cancer Patients...
Hutchmed China Ltd on Tuesday reported it was granted conditional approval in China for an injection to treat endomet ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 2 | 0.826446280992 | 242 | 259 | 241 | 44701 | 249.66304634 | DE |
4 | -21 | -7.92452830189 | 265 | 269 | 225 | 66947 | 242.78867887 | DE |
12 | -54 | -18.1208053691 | 298 | 336 | 225 | 70958 | 280.22512886 | DE |
26 | -36 | -12.8571428571 | 280 | 336 | 225 | 105714 | 289.77068417 | DE |
52 | -8.5 | -3.36633663366 | 252.5 | 353 | 190.4 | 86019 | 284.11790276 | DE |
156 | -275 | -52.9865125241 | 519 | 519 | 130 | 98217 | 250.34154384 | DE |
260 | -156 | -39 | 400 | 656 | 130 | 101172 | 347.12148967 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions